As of May 2, 2023, the outbreak of the coronavirus disease (COVID-19) had been confirmed in almost every country in the world. The virus had infected over 687 million people worldwide, and the number of deaths had reached almost 6.87 million. The most severely affected countries include the U.S., India, and Brazil.

COVID-19: background information COVID-19 is a novel coronavirus that had not previously been identified in humans. The first case was detected in the Hubei province of China at the end of December 2019. The virus is highly transmissible and coughing and sneezing are the most common forms of transmission, which is similar to the outbreak of the SARS coronavirus that began in 2002 and was thought to have spread via cough and sneeze droplets expelled into the air by infected persons.

Naming the coronavirus disease Coronaviruses are a group of viruses that can be transmitted between animals and people, causing illnesses that may range from the common cold to more severe respiratory syndromes. In February 2020, the International Committee on Taxonomy of Viruses and the World Health Organization announced official names for both the virus and the disease it causes: SARS-CoV-2 and COVID-19, respectively. The name of the disease is derived from the words corona, virus, and disease, while the number 19 represents the year that it emerged.

As of November 14, 2022, the United States had recorded almost 98 million cases of COVID-19. The country had also reported a total number of over one million deaths from the disease.

COVID-19 testing remains important The cumulative number of coronavirus cases worldwide reached almost 633 million towards the beginning of November 2022. Demand for test kits has at times exceeded production levels, but many countries continue to test citizens to more effectively control rises in cases. The U.S. has performed the most tests worldwide, followed by India and the United Kingdom.

The silent spread of the coronavirus Widespread testing will also help to detect people who might be asymptomatic – showing few or no symptoms of the illness. These carriers are unwittingly transmitting the virus to others, and the threat of silent transmission is one reason why mass lockdowns have been imposed around the world. However, as asymptomatic carriers produce no symptoms, they may have developed some natural immunity to the illness. Viruses are not as easily spread in communities with high rates of immunity, which helps to protect more vulnerable groups of people. When an infection rate is less than one, a community has achieved herd immunity.

On March 10, 2023, the Johns Hopkins Coronavirus Resource Center ceased its collecting and reporting of global COVID-19 data. For updated cases, deaths, and vaccine data please visit: World Health Organization (WHO)For more information, visit the Johns Hopkins Coronavirus Resource Center.COVID-19 Trends MethodologyOur goal is to analyze and present daily updates in the form of recent trends within countries, states, or counties during the COVID-19 global pandemic. The data we are analyzing is taken directly from the Johns Hopkins University Coronavirus COVID-19 Global Cases Dashboard, though we expect to be one day behind the dashboard’s live feeds to allow for quality assurance of the data.DOI: https://doi.org/10.6084/m9.figshare.125529863/7/2022 - Adjusted the rate of active cases calculation in the U.S. to reflect the rates of serious and severe cases due nearly completely dominant Omicron variant.6/24/2020 - Expanded Case Rates discussion to include fix on 6/23 for calculating active cases.6/22/2020 - Added Executive Summary and Subsequent Outbreaks sectionsRevisions on 6/10/2020 based on updated CDC reporting. This affects the estimate of active cases by revising the average duration of cases with hospital stays downward from 30 days to 25 days. The result shifted 76 U.S. counties out of Epidemic to Spreading trend and no change for national level trends.Methodology update on 6/2/2020: This sets the length of the tail of new cases to 6 to a maximum of 14 days, rather than 21 days as determined by the last 1/3 of cases. This was done to align trends and criteria for them with U.S. CDC guidance. The impact is areas transition into Controlled trend sooner for not bearing the burden of new case 15-21 days earlier.Correction on 6/1/2020Discussion of our assertion of an abundance of caution in assigning trends in rural counties added 5/7/2020. Revisions added on 4/30/2020 are highlighted.Revisions added on 4/23/2020 are highlighted.Executive SummaryCOVID-19 Trends is a methodology for characterizing the current trend for places during the COVID-19 global pandemic. Each day we assign one of five trends: Emergent, Spreading, Epidemic, Controlled, or End Stage to geographic areas to geographic areas based on the number of new cases, the number of active cases, the total population, and an algorithm (described below) that contextualize the most recent fourteen days with the overall COVID-19 case history. Currently we analyze the countries of the world and the U.S. Counties. The purpose is to give policymakers, citizens, and analysts a fact-based data driven sense for the direction each place is currently going. When a place has the initial cases, they are assigned Emergent, and if that place controls the rate of new cases, they can move directly to Controlled, and even to End Stage in a short time. However, if the reporting or measures to curtail spread are not adequate and significant numbers of new cases continue, they are assigned to Spreading, and in cases where the spread is clearly uncontrolled, Epidemic trend.We analyze the data reported by Johns Hopkins University to produce the trends, and we report the rates of cases, spikes of new cases, the number of days since the last reported case, and number of deaths. We also make adjustments to the assignments based on population so rural areas are not assigned trends based solely on case rates, which can be quite high relative to local populations.Two key factors are not consistently known or available and should be taken into consideration with the assigned trend. First is the amount of resources, e.g., hospital beds, physicians, etc.that are currently available in each area. Second is the number of recoveries, which are often not tested or reported. On the latter, we provide a probable number of active cases based on CDC guidance for the typical duration of mild to severe cases.Reasons for undertaking this work in March of 2020:The popular online maps and dashboards show counts of confirmed cases, deaths, and recoveries by country or administrative sub-region. Comparing the counts of one country to another can only provide a basis for comparison during the initial stages of the outbreak when counts were low and the number of local outbreaks in each country was low. By late March 2020, countries with small populations were being left out of the mainstream news because it was not easy to recognize they had high per capita rates of cases (Switzerland, Luxembourg, Iceland, etc.). Additionally, comparing countries that have had confirmed COVID-19 cases for high numbers of days to countries where the outbreak occurred recently is also a poor basis for comparison.The graphs of confirmed cases and daily increases in cases were fit into a standard size rectangle, though the Y-axis for one country had a maximum value of 50, and for another country 100,000, which potentially misled people interpreting the slope of the curve. Such misleading circumstances affected comparing large population countries to small population counties or countries with low numbers of cases to China which had a large count of cases in the early part of the outbreak. These challenges for interpreting and comparing these graphs represent work each reader must do based on their experience and ability. Thus, we felt it would be a service to attempt to automate the thought process experts would use when visually analyzing these graphs, particularly the most recent tail of the graph, and provide readers with an a resulting synthesis to characterize the state of the pandemic in that country, state, or county.The lack of reliable data for confirmed recoveries and therefore active cases. Merely subtracting deaths from total cases to arrive at this figure progressively loses accuracy after two weeks. The reason is 81% of cases recover after experiencing mild symptoms in 10 to 14 days. Severe cases are 14% and last 15-30 days (based on average days with symptoms of 11 when admitted to hospital plus 12 days median stay, and plus of one week to include a full range of severely affected people who recover). Critical cases are 5% and last 31-56 days. Sources:U.S. CDC. April 3, 2020 Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19). Accessed online. Initial older guidance was also obtained online. Additionally, many people who recover may not be tested, and many who are, may not be tracked due to privacy laws. Thus, the formula used to compute an estimate of active cases is: Active Cases = 100% of new cases in past 14 days + 19% from past 15-25 days + 5% from past 26-49 days - total deaths. On 3/17/2022, the U.S. calculation was adjusted to: Active Cases = 100% of new cases in past 14 days + 6% from past 15-25 days + 3% from past 26-49 days - total deaths. Sources: https://www.cdc.gov/mmwr/volumes/71/wr/mm7104e4.htm https://covid.cdc.gov/covid-data-tracker/#variant-proportions If a new variant arrives and appears to cause higher rates of serious cases, we will roll back this adjustment. We’ve never been inside a pandemic with the ability to learn of new cases as they are confirmed anywhere in the world. After reviewing epidemiological and pandemic scientific literature, three needs arose. We need to specify which portions of the pandemic lifecycle this map cover. The World Health Organization (WHO) specifies six phases. The source data for this map begins just after the beginning of Phase 5: human to human spread and encompasses Phase 6: pandemic phase. Phase six is only characterized in terms of pre- and post-peak. However, these two phases are after-the-fact analyses and cannot ascertained during the event. Instead, we describe (below) a series of five trends for Phase 6 of the COVID-19 pandemic.Choosing terms to describe the five trends was informed by the scientific literature, particularly the use of epidemic, which signifies uncontrolled spread. The five trends are: Emergent, Spreading, Epidemic, Controlled, and End Stage. Not every locale will experience all five, but all will experience at least three: emergent, controlled, and end stage.This layer presents the current trends for the COVID-19 pandemic by country (or appropriate level). There are five trends:Emergent: Early stages of outbreak. Spreading: Early stages and depending on an administrative area’s capacity, this may represent a manageable rate of spread. Epidemic: Uncontrolled spread. Controlled: Very low levels of new casesEnd Stage: No New cases These trends can be applied at several levels of administration: Local: Ex., City, District or County – a.k.a. Admin level 2State: Ex., State or Province – a.k.a. Admin level 1National: Country – a.k.a. Admin level 0Recommend that at least 100,000 persons be represented by a unit; granted this may not be possible, and then the case rate per 100,000 will become more important.Key Concepts and Basis for Methodology: 10 Total Cases minimum threshold: Empirically, there must be enough cases to constitute an outbreak. Ideally, this would be 5.0 per 100,000, but not every area has a population of 100,000 or more. Ten, or fewer, cases are also relatively less difficult to track and trace to sources. 21 Days of Cases minimum threshold: Empirically based on COVID-19 and would need to be adjusted for any other event. 21 days is also the minimum threshold for analyzing the “tail” of the new cases curve, providing seven cases as the basis for a likely trend (note that 21 days in the tail is preferred). This is the minimum needed to encompass the onset and duration of a normal case (5-7 days plus 10-14 days). Specifically, a median of 5.1 days incubation time, and 11.2 days for 97.5% of cases to incubate. This is also driven by pressure to understand trends and could easily be adjusted to 28 days. Source

This dataset provides values for CORONAVIRUS CASES reported in several countries. The data includes current values, previous releases, historical highs and record lows, release frequency, reported unit and currency.

This dataset provides values for CORONAVIRUS DEATHS reported in several countries. The data includes current values, previous releases, historical highs and record lows, release frequency, reported unit and currency.

Based on a comparison of coronavirus deaths in 210 countries relative to their population, Peru had the most losses to COVID-19 up until July 13, 2022. As of the same date, the virus had infected over 557.8 million people worldwide, and the number of deaths had totaled more than 6.3 million. Note, however, that COVID-19 test rates can vary per country. Additionally, big differences show up between countries when combining the number of deaths against confirmed COVID-19 cases. The source seemingly does not differentiate between "the Wuhan strain" (2019-nCOV) of COVID-19, "the Kent mutation" (B.1.1.7) that appeared in the UK in late 2020, the 2021 Delta variant (B.1.617.2) from India or the Omicron variant (B.1.1.529) from South Africa.

The difficulties of death figures

This table aims to provide a complete picture on the topic, but it very much relies on data that has become more difficult to compare. As the coronavirus pandemic developed across the world, countries already used different methods to count fatalities, and they sometimes changed them during the course of the pandemic. On April 16, for example, the Chinese city of Wuhan added a 50 percent increase in their death figures to account for community deaths. These deaths occurred outside of hospitals and went unaccounted for so far. The state of New York did something similar two days before, revising their figures with 3,700 new deaths as they started to include “assumed” coronavirus victims. The United Kingdom started counting deaths in care homes and private households on April 29, adjusting their number with about 5,000 new deaths (which were corrected lowered again by the same amount on August 18). This makes an already difficult comparison even more difficult. Belgium, for example, counts suspected coronavirus deaths in their figures, whereas other countries have not done that (yet). This means two things. First, it could have a big impact on both current as well as future figures. On April 16 already, UK health experts stated that if their numbers were corrected for community deaths like in Wuhan, the UK number would change from 205 to “above 300”. This is exactly what happened two weeks later. Second, it is difficult to pinpoint exactly which countries already have “revised” numbers (like Belgium, Wuhan or New York) and which ones do not. One work-around could be to look at (freely accessible) timelines that track the reported daily increase of deaths in certain countries. Several of these are available on our platform, such as for Belgium, Italy and Sweden. A sudden large increase might be an indicator that the domestic sources changed their methodology.

Where are these numbers coming from?

The numbers shown here were collected by Johns Hopkins University, a source that manually checks the data with domestic health authorities. For the majority of countries, this is from national authorities. In some cases, like China, the United States, Canada or Australia, city reports or other various state authorities were consulted. In this statistic, these separately reported numbers were put together. For more information or other freely accessible content, please visit our dedicated Facts and Figures page.

The New York Times is releasing a series of data files with cumulative counts of coronavirus cases in the United States, at the state and county level, over time. We are compiling this time series data from state and local governments and health departments in an attempt to provide a complete record of the ongoing outbreak.

Since the first reported coronavirus case in Washington State on Jan. 21, 2020, The Times has tracked cases of coronavirus in real time as they were identified after testing. Because of the widespread shortage of testing, however, the data is necessarily limited in the picture it presents of the outbreak.

We have used this data to power our maps and reporting tracking the outbreak, and it is now being made available to the public in response to requests from researchers, scientists and government officials who would like access to the data to better understand the outbreak.

The data begins with the first reported coronavirus case in Washington State on Jan. 21, 2020. We will publish regular updates to the data in this repository.

The World Health Organization reported 766440796 Coronavirus Cases since the epidemic began. In addition, countries reported 6932591 Coronavirus Deaths. This dataset provides - World Coronavirus Cases- actual values, historical data, forecast, chart, statistics, economic calendar and news.

As of November 24, 2024 there were over 274 million confirmed cases of coronavirus (COVID-19) across the whole of Europe since the first confirmed cases in France in January 2020. France has been the worst affected country in Europe with 39,028,437 confirmed cases, followed by Germany with 38,437,756 cases. Italy and the UK have approximately 26.8 million and 25 million cases respectively. For further information about the coronavirus pandemic, please visit our dedicated Facts and Figures page.

This dataset provides values for CORONAVIRUS CASES reported in several countries. The data includes current values, previous releases, historical highs and record lows, release frequency, reported unit and currency.

As of May 2, 2023, the coronavirus disease (COVID-19) had been confirmed in almost every country and territory around the world. There had been roughly 687 million cases and 6.86 million deaths.

Vaccine approval in the United States The United States has recorded more coronavirus infections and deaths than any other country in the world. The regulatory agency in the country authorized three COVID-19 vaccines for emergency use. Both the Pfizer-BioNTech and Moderna vaccines were approved in December 2020, while the Johnson & Johnson vaccine was approved in February 2021. As of April 26, 2023, the number of COVID-19 vaccine doses administered in the U.S. had reached 675 million.

The difference between vaccines and antivirals Medications can help with the symptoms of viruses, but it is the role of the immune system to take care of them over time. However, the use of vaccines and antivirals can help the immune system in doing its job. The most tried and tested vaccine method is to inject an inactive or weakened form of a virus, encouraging the immune system to produce protective antibodies. The immune system keeps the virus in its memory, and if the real one appears, the body will recognize it and attack it more efficiently. Antivirals are designed to help target viruses, limiting their ability to reproduce and spread to other cells. They are used by patients who are already infected by a virus and can make the infection less severe.

Abstract

JHU Coronavirus COVID-19 Global Cases, by country

Documentation

PHS is updating the Coronavirus Global Cases dataset weekly, Monday, Wednesday and Friday from Cloud Marketplace.

This data comes from the data repository for the 2019 Novel Coronavirus Visual Dashboard operated by the Johns Hopkins University Center for Systems Science and Engineering (JHU CSSE). This database was created in response to the Coronavirus public health emergency to track reported cases in real-time. The data include the location and number of confirmed COVID-19 cases, deaths, and recoveries for all affected countries, aggregated at the appropriate province or state. It was developed to enable researchers, public health authorities and the general public to track the outbreak as it unfolds. Additional information is available in the blog post.

Visual Dashboard (desktop): https://www.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6

Section 2

Included Data Sources are:

• World Health Organization (WHO): https://www.who.int/
• DXY.cn. Pneumonia. 2020. http://3g.dxy.cn/newh5/view/pneumonia.
• BNO News: https://bnonews.com/index.php/2020/02/the-latest-coronavirus-cases/
• National Health Commission of the People’s Republic of China (NHC): http://www.nhc.gov.cn/xcs/yqtb/list_gzbd.shtml
• China CDC (CCDC): http://weekly.chinacdc.cn/news/TrackingtheEpidemic.htm
• Hong Kong Department of Health: https://www.chp.gov.hk/en/features/102465.html
• Macau Government: https://www.ssm.gov.mo/portal/
• Taiwan CDC: https://sites.google.com/cdc.gov.tw/2019ncov/taiwan?authuser=0
• US CDC: https://www.cdc.gov/coronavirus/2019-ncov/index.html
• Government of Canada: https://www.canada.ca/en/public-health/services/diseases/coronavirus.html
• Australia Government Department of Health: https://www.health.gov.au/news/coronavirus-update-at-a-glance
• European Centre for Disease Prevention and Control (ECDC): https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases
• Ministry of Health Singapore (MOH): https://www.moh.gov.sg/covid-19
• Italy Ministry of Health: http://www.salute.gov.it/nuovocoronavirus
• 1Point3Arces: https://coronavirus.1point3acres.com/en
• WorldoMeters: https://www.worldometers.info/coronavirus/

%3C!-- --%3E

Section 3

**Terms of Use: **

This GitHub repo and its contents herein, including all data, mapping, and analysis, copyright 2020 Johns Hopkins University, all rights reserved, is provided to the public strictly for educational and academic research purposes. The Website relies upon publicly available data from multiple sources, that do not always agree. The Johns Hopkins University hereby disclaims any and all representations and warranties with respect to the Website, including accuracy, fitness for use, and merchantability. Reliance on the Website for medical guidance or use of the Website in commerce is strictly prohibited.

Section 4

**U.S. county-level characteristics relevant to COVID-19 **

Chin, Kahn, Krieger, Buckee, Balsari and Kiang (forthcoming) show that counties differ significantly in biological, demographic and socioeconomic factors that are associated with COVID-19 vulnerability. A range of publicly available county-specific data identifying these key factors, guided by international experiences and consideration of epidemiological parameters of importance, have been combined by the authors and are available for use:

https://github.com/mkiang/county_preparedness/

As of January 13, 2023, there had been over 270 million confirmed cases of COVID-19 across the whole of Europe since the first confirmed case in January, 2020. Cyprus has the highest incidence of COVID-19 cases among its population in Europe at 71,853 per 100,000 people, followed by a rate of 64,449 in Austria. Slovenia has recorded the third highest rate of cases in Europe at 62,834 cases per 100,000. With almost 38.3 million confirmed cases, France has been the worst affected country in Europe, which translates into a rate of 58,945 cases per 100,000 population.

Current infection rate in Europe San Marino had the highest rate of cases per 100,000 in the past week at 336, as of January 16, 2023. Cyprus and Slovenia had seven day rates of infections at 278 and 181 respectively.

Coronavirus deaths in Europe There have been 2,169,191 recorded COVID-19 deaths in Europe since the beginning of the pandemic. Russia has the highest number of deaths recorded in a European country at over 394 thousand. Bulgaria has the highest death rate from the virus in Europe with approximately 549 deaths per 100,000 as of January 13, followed by Hungary with 496 deaths per 100,000. For further information about the coronavirus pandemic, please visit our dedicated Facts and Figures page.

This dataset provides values for CORONAVIRUS CASES reported in several countries. The data includes current values, previous releases, historical highs and record lows, release frequency, reported unit and currency.

2019 Novel Coronavirus COVID-19 (2019-nCoV) Visual Dashboard and Map:
https://www.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6

• Confirmed Cases by Country/Region/Sovereignty
• Confirmed Cases by Province/State/Dependency
• Deaths
• Recovered

Downloadable data:
https://github.com/CSSEGISandData/COVID-19

Additional Information about the Visual Dashboard:
https://systems.jhu.edu/research/public-health/ncov

Context

Had searched for many resources but finally I extracted this data and cleaned it a bit from an api.

Content

It has the following columns: country name, date, total confirmed, total recovered, total deaths.

The outbreak of the novel coronavirus in Wuhan, China, saw infection cases spread throughout the Asia-Pacific region. By April 13, 2024, India had faced over 45 million coronavirus cases. South Korea followed behind India as having had the second highest number of coronavirus cases in the Asia-Pacific region, with about 34.6 million cases. At the same time, Japan had almost 34 million cases. At the beginning of the outbreak, people in South Korea had been optimistic and predicted that the number of cases would start to stabilize. What is SARS CoV 2?Novel coronavirus, officially known as SARS CoV 2, is a disease which causes respiratory problems which can lead to difficulty breathing and pneumonia. The illness is similar to that of SARS which spread throughout China in 2003. After the outbreak of the coronavirus, various businesses and shops closed to prevent further spread of the disease. Impacts from flight cancellations and travel plans were felt across the Asia-Pacific region. Many people expressed feelings of anxiety as to how the virus would progress. Impact throughout Asia-PacificThe Coronavirus and its variants have affected the Asia-Pacific region in various ways. Out of all Asia-Pacific countries, India was highly affected by the pandemic and experienced more than 50 thousand deaths. However, the country also saw the highest number of recoveries within the APAC region, followed by South Korea and Japan.

Context

From World Health Organization - On 31 December 2019, WHO was alerted to several cases of pneumonia in Wuhan City, Hubei Province of China. The virus did not match any other known virus. This raised concern because when a virus is new, we do not know how it affects people.

So daily level information on the affected people can give some interesting insights when it is made available to the broader data science community.

The European CDC publishes daily statistics on the COVID-19 pandemic. Not just for Europe, but for the entire world. We rely on the ECDC as they collect and harmonize data from around the world which allows us to compare what is happening in different countries.

Content

This dataset has daily level information on the number of affected cases, deaths and recovery etc. from coronavirus. It also contains various other parameters like average life expectancy, population density, smocking population etc. which users can find useful in further prediction that they need to make.

The data is available from 31 Dec,2019.

Inspiration

Give people weekly data so that they can use it to make accurate predictions.

The Novel Coronavirus (COVID-19) daily data of confirmed cases for affected countries and provinces of China reported between 31st December 2019 and 31st May 2020. The data was collected from the European Centre for Disease Prevention and Control (ECDC), and John Hopkin CSSA. The monthly mean temperature of February to May 2020 of capital cities for the various nations.